adjuvant chemotherapy for head and neck cancer
Showing 1 - 25 of >10,000
Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma Trial in Boston
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +3 more
- Pembrolizumab
- +3 more
-
Boston, Massachusetts
- +1 more
Feb 11, 2023
Hypopharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Larynx Cancer Trial in United Kingdom (AZD1775,
Completed
- Hypopharynx Squamous Cell Carcinoma
- +2 more
- AZD1775
- +2 more
-
Birmingham, West Midlands, United Kingdom
- +5 more
Nov 9, 2022
Head-and-neck Squamous Cell Carcinoma Trial in Germany (De-escalation radio(chemo)therapy - Level 1, De-escalation
Recruiting
- Head-and-neck Squamous Cell Carcinoma
- De-escalation radio(chemo)therapy - Level 1
- +2 more
-
Freiburg, Baden-Wuerttemberg, Germany
- +9 more
Aug 2, 2022
Head and Neck Squamous Cell Carcinoma Trial in Chongqing (Camrelizumab, Concurrent cisplatin chemo, Intensity-modulated
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Camrelizumab
- +2 more
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Jan 16, 2022
Head and Neck Squamous Cell Carcinoma, Cancer, Cancer of Head and Neck Trial in United States (Pembrolizumab, Radiation therapy,
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Pembrolizumab
- +2 more
-
Tucson, Arizona
- +6 more
Oct 7, 2021
Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Penpulimab injection, cisplatin, albumin-paclitaxel)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Penpulimab injection
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hostipal, Shanghai Jiao Tong University
Oct 7, 2023
Head Neck Cancer, Head Cancer, Head Cancer Neck Trial in United States (drug, procedure, radiation)
Recruiting
- Head and Neck Cancer
- +5 more
- Cisplatin
- +6 more
-
Basking Ridge, New Jersey
- +5 more
Jan 19, 2023
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Experimental Observation
- +3 more
-
Baltimore, Maryland
- +5 more
Oct 16, 2023
HPV-Related Squamous Cell Carcinoma, HNSCC Trial in Chicago (drug, procedure, radiation)
Active, not recruiting
- HPV-Related Squamous Cell Carcinoma
- HNSCC
- nab-paclitaxel
- +12 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Nov 12, 2021
Head and Neck Squamous Cell Carcinomas Trial in Guanzhou (drug, procedure, radiation)
Recruiting
- Head and Neck Squamous Cell Carcinomas
- Tislelizumab（neoadjuvant）
- +6 more
-
Guanzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Oct 28, 2022
Head and Neck Squamous-cell Carcinoma
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- +2 more
- (no location specified)
Nov 5, 2023
Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy, Pembrolizumab Trial in Beijing (Pembrolizumab, Cisplatin,
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +2 more
- Pembrolizumab
- +7 more
-
Beijing, Beijing, ChinaBeijing Tongren Hospital
Oct 26, 2023
Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Nab paclitaxel
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Aug 24, 2023
Head Neck Cancer Trial in Washington (Cisplatinum, Docetaxel, Carboplatin)
Active, not recruiting
- Head and Neck Cancer
- Cisplatinum
- +3 more
-
Washington, District of ColumbiaGeorge Washington University-Medical Faculty Associates
Nov 14, 2022
Cancer of Head and Neck, Head Neck Cancer, Tumors, Head and Neck Trial in Boston, Saint Louis, New York (biological, procedure,
Active, not recruiting
- Cancer of Head and Neck
- +5 more
- MK-3475 (neoadjuvant)
- +6 more
-
Boston, Massachusetts
- +2 more
Dec 9, 2022
Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,
Not yet recruiting
- Head and Neck Cancer
- +2 more
- Xevinapant
- +3 more
-
Chicago, IllinoisUniversity of Chicago Medicine Comprehensive Cancer Center
Oct 25, 2023
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial (ENDURE)
Not yet recruiting
- Head and Neck Cancer
- +4 more
- ENDURE
- (no location specified)
Apr 2, 2023
Tinnitus and Hearing Loss in Locally Advanced Head and Neck
Not yet recruiting
- Head Cancer
- Neck Cancer
-
Paris, FranceRadiotherapy Oncology Service TENON Hospital
Jul 7, 2023
Head Neck Cancer, Oral Mucositis, Pain Trial (hydrogen water)
Not yet recruiting
- Head and Neck Cancer
- +3 more
- hydrogen water
- (no location specified)
Jun 13, 2023
Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Toripalimab+cetuximab)
Recruiting
- Patients With Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma
-
Shanghai, Shanghai, Chinathe Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
Nov 1, 2022
Squamous Cell Carcinoma of the Oropharynx Trial in United States (Radiation Therapy)
Not yet recruiting
- Squamous Cell Carcinoma of the Oropharynx
- Radiation Therapy
-
Miami, Florida
- +3 more
Jul 22, 2023
Lung Cancer, Head Neck Cancer, Esophageal Cancer Trial in Seoul (Fitbit smartwatch)
Recruiting
- Lung Cancer
- +2 more
- Fitbit smartwatch
-
Seoul, Gangnamgu, Korea, Republic ofSamsung Medical Center
Jun 30, 2023
Resectable Head and Neck Squamous Cell Carcinoma Trial in Milwaukee (42 Gy Radiation Therapy, 39 Gy Radiation Therapy, 32.5 Gy
Suspended
- Resectable Head and Neck Squamous Cell Carcinoma
- 42 Gy Radiation Therapy
- +2 more
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Jan 13, 2023
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in United States (Nivolumab, Cisplatin, Cetuximab)
Completed
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Nivolumab
- +3 more
-
Palo Alto, California
- +10 more
Nov 22, 2022